ModeX and Regeneron Partner to Develop Multispecific Antibodies
ModeX Therapeutics has entered into a research collaboration with Regeneron to develop multispecific antibodies capable of targeting multiple biological pathways within a single molecule. The partnership, valued at over USD 1 Billion, if multiple assets advance, aims to accelerate innovation across select therapeutic areas.
Antibodies | 30/10/2025 | By Dineshwori | 107
Abzena Welcomes Taylor Boyd as New CBO
Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities.
Antibodies | 27/02/2025 | By Aishwarya | 467
AstraZeneca Acquires Fusion Pharmaceuticals to Transform Cancer Treatment
Fusion Pharmaceuticals Inc. has signed a definitive agreement to be acquired by AstraZeneca.
Antibodies | 20/03/2024 | By Manvi | 644
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy